Photothermal‐boosted polaron transport in Fe_(2)O_(3)photoanodes for efficient photoelectrochemical water splitting

Introduction of the photothermal effect into transition-metal oxide photoanodes has been proven to be an effective method to improve the photoelectrochemical(PEC)water-splitting performance.However,the precise role of the photothermal effect on the PEC performance of photoanodes is still not well understood.Herein,spinel-structured ZnFe_(2)O_(4)nanoparticles are deposited on the surface of hematite(Fe_(2)O_(3)),and the ZnFe_(2)O_(4)/Fe_(2)O_(3)photoanode achieves a high photocurrent density of 3.17 mA cm^(-2)at 1.23 V versus a reversible hydrogen electrode(VRHE)due to the photothermal effect of ZnFe_(2)O_(4).Considering that the hopping of electron small polarons induced by oxygen vacancies is thermally activated,we clarify that the main reason for the enhanced PEC performance via the photothermal effect is the promoted mobility of electron small polarons that are bound to positively charged oxygen vacancies.Under the synergistic effect of oxygen vacancies and the photothermal effect,the electron conductivity and PEC performance are significantly improved,which provide fundamental insights into the impact of the photothermal effect on the PEC performance of small polaron-type semiconductor photoanodes.

Adaptive detection in the presence of signal mismatch

The problem of adaptive detection in the situation of signal mismatch is considered; that is, the actual signal steering vector is not aligned with the nominal one. Two novel tunable detectors are proposed. They can control the degree to which the mismatched signals are rejected. Remarkably, it is found that they both cover existing famous detectors as their special cases. More importantly, they possess the constant false alarm rate（CFAR）property and achieve enhanced mismatched signal rejection or improved robustness than their natural competitors. Besides, they can provide slightly better matched signals detection performance than the existing detectors.

Effects of Mangiferin on the Expression of TNF-α,iNos,ICAM-1 and Its mRNA in the Heart,Brain and Kidneys of SHR

[Objectives] To study the effects of Mangiferin( MGF) on TNF-α,iNOS,ICAM-1 and its mRNA expression in the heart,brain and kidneys of spontaneously hypertensive rats( SHR),and reveal the mechanism of its anti-inflammatory injury in hypertension target organs.[Methods]SHRs were randomly divided into 5 groups: the model group,the high-dose,medium-dose,low-dose MGF groups and the Benazepril group,with 8 rats in each group,WKY rats were used for the normal control group. Besides,on-invasive blood pressure( BP) instruments were used to measure systolic blood pressure in the rats' tail artery,western blot was used to analyze the expression of TNF-α,iNOS,ICAM-1 and reverse transcription-polymerase chain reaction( RT-PCR) was used to analyze the expression of TNF-α,iNOS,ICAM-1 mRNA.[Results]Compared with the normal control group,the model group's BP level was significantly increased( P <0. 01)),but the MGF had no significant lowering BP effect( P > 0. 05); compared with the normal control group,the expression of TNF-α,iNOS,ICAM-1 and its' mRNA in the model group was significantly increased( P < 0. 05 or P < 0. 01),and MGF could reduce the level of expression of these inflammatory cytokines( P < 0. 05 or P < 0. 01); between the Benazepril group and high-dose,medium-dose,low-dose MGF groups,most of the indicators had no significant difference( P > 0. 05). [Conclusions]MGF had no significant lowering BP effect,SHR showed inflammatory injury in the heart,brain and kidneys,MGF showed improvement on the inflammatory injury,and the anti-inflammation mechanism may be associated with lowering TNF-α,i NOS and ICAM-1 and its mRNA expression.

芒果苷通过抑制MCP-1/CCR2信号通路减轻自发性高血压大鼠心脏炎症损伤

高血压是一种低度炎症状态的疾病,通常伴有心脏炎症。芒果苷(MGF)是一种天然糖基蒽酮,具有很强的抗炎活性。然而,MGF对高血压患者心脏炎症损伤的作用尚不清楚。本文研究MGF对自发性高血压大鼠(SHRs)心脏炎症损伤的保护作用及其机制。采用10周龄雄性SHRs和10周龄正常雄性Wistar-Kyoto(WKY)大鼠,对SHRs使用10、20、40 mg/kg剂量的MGF,连续8周。测量其收缩压(SBP)水平,采集心脏组织进行形态学、免疫组化、ELISA、western blot和实时反转录PCR分析。结果表明模型组大鼠收缩压水平均较对照组显著升高,SHRs自发升高收缩压水平,各剂量MGF对收缩压水平无显著影响。模型组大鼠心脏组织形态学结果显示有明显的炎症性损伤,MGF对这种损伤有显著的抑制作用。同时,MGF显著抑制了SHRs IL-6和TNF-α含量的升高。此外,MGF还显著抑制了SHRs MCP-1、CCR2蛋白以及其mRNA表达的增加。研究表明MGF并不会降低SHRs大鼠的SBP水平,但MGF对SHRs大鼠的心脏炎症损伤具有保护作用,这可能是因为MGF部分抑制了MCP-1/CCR2信号通路表达的原因。

Mangiferin alleviates renal infammatory injury in spontaneously hypertensive rats by inhibiting MCP-1/CCR2 signaling pathway

Objective: Hypertension is a low-grade infammation state of the disease and was easily complicated by kidneys’ infammatory response. Mangiferin(MGF), a pharmacologically active compound in various plants including Mangifera indica, has a strong anti-infammatory activity. However, the effects of MGF on renal infammatory injury in spontaneously hypertensive rats(SHRs) remain unclear. The purpose of this study was to investigate the protective effects and mechanisms of MGF on renal infammatory injury in SHRs.Methods: MGF was used in SHRs at the doses of 10, 20, 40 mg/kg/d for 8 weeks consecutively. The blood and urine were collected for assessment of renal function. Renal tissues were collected for histological,immunohistochemistry, ELISA, Western blot and real time reverse transcription PCR(RT-PCR) analysis.Results: The results showed that the levels of interleukin 6(IL-6), tumor necrosis factor-a(TNF-a), monocyte chemoattractant protein-1(MCP-1) and recombinant chemokine C-C-Motif receptor 2(CCR2) were increased in SHRs, meanwhile, the level of IL-10 was decreased in SHR. Treatment of MGF inhibited the expression of IL-6, TNF-a, MCP-1 and CCR2, and promoted the expression of IL-10. Furthermore, the content of blood urea nitrogen(BUN) and serum uric acid(SUA) was significantly increased in the model group, and treatment of MGF had no obvious effects on these parameters at all dose levels.Conclusion: Our study proved that the kidneys of SHRs had significant infammatory injury, and MGF had the protective effects on renal infammatory injury in SHRs;The protective mechanism may be mediated partly by the MCP-1/CCR2 signaling pathway. Thus, it is a potential new drug for the treatment of hypertension.